Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer

BACKGROUND: Patients with curable esophageal cancer (EC) who proceed beyond the original Chemoradiotherapy for Oesophageal Cancer Followed by Surgery Study (CROSS) eligibility criteria are also treated with neoadjuvant chemoradiotherapy (nCRT). This study assessed the effect that extending the CROSS...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Surg Oncol
Hlavní autoři: de Heer, E. C., Hulshoff, J. B., Klerk, D., Burgerhof, J. G. M., de Groot, D. J. A., Plukker, J. Th. M., Hospers, G. A. P.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2017
Témata:
Gastrointestinal Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5486922/
https://ncbi.nlm.nih.gov/pubmed/28188501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-017-5797-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky